Natalie Gladstein, MD, University of Michigan

Objective 1 – We will conduct a cross-sectional survey of community-based obstetrician-gynecologists and family physicians in Michigan about their knowledge and experiences with abortion services. We will sample these physicians in person at their annual meetings, through an online survey, and mail letters to their offices with incentives encouraging participation. The survey will also provide ...Read more >

Jessica Lee, MD, Johns Hopkins University

Despite the widespread use of osmotic dilators for cervical preparation for dilation and evacuation, there are minimal data regarding patient pain management during dilator placement.This will be a randomized, double- blind, placebo-controlled trial including women aged 18-50 years with a live intrauterine pregnancy between the gestational ages of 17w0d and 23w5d presenting for cervical dilator ...Read more >

Jennifer Hsia , MD, MPH, University of California, Davis

This is a retrospective cohort study evaluating the effectiveness of early medication abortion between 64-70 days gestation in the UK using a mifepristone and vaginal misoprostol regimen. This study will be performed in collaboration with BPAS, whose abortion data specifically for this gestational age is impressive, with over 2700 cases of early medication abortion. This ...Read more >

Andrea Roe, MD, Planned Parenthood League of Massachusetts

This is a retrospective observational cohort study of long-acting reversible contraception uptake by women presenting for surgical abortion care at Planned Parenthood League of Massachusetts (PPLM).  Using electronic medical records, we calculated a modern estimate of immediate post-abortion LARC use in a clinic setting with minimal structural barriers to LARC provision, as well as demographic and medical ...Read more >

Aaron Lazorwitz, MD, University of Colorado

Pharmacogenomics is the study of how individual genetic differences affect drug metabolism, efficacy, and side effects. Women using the exact same contraceptive method for the same period of time have wide variability in both serum drug levels and side effect profiles from their contraception. This pharmacogenomic study aimed to help us better understand how individual ...Read more >

Stacey Leigh Rubin, MD, Johns Hopkins University

The primary purpose of this study is to describe bleeding patterns on the LNG-IUS and the ENG implant following DMPA use, and to compare this with prior bleeding patterns on DMPA. Secondary objectives are to explore whether bleeding pattern on subsequent progestin LARC is associated with the duration of prior DMPA use, and will characterize ...Read more >

Dominika Seidman, MD, University of California, San Francisco

The purpose of this study is to assess the acceptability and feasibility, and to gain insights into content, of an electronic decision support tool integrating family planning and HIV prevention options among key stakeholders at family planning clinics in Kisumu, Kenya.  The primary research question, What are family planning clients’, clinicians’, and health educators’ attitudes ...Read more >

Noah Nattell, MD, University of Southern California

Background: Over 200,000 women are incarcerated in the United States, and 94% are of reproductive age.  While over 80% of women in jail report a lifetime history of unintended pregnancy, ambivalence and indifference are common attitudes toward pregnancy.  The Centers for Disease Control has recommended incorporation of Reproductive Life Planning (RLP) into all health visits, ...Read more >

Shanthi Ramesh, MD, The University of North Carolina at Chapel Hill

Background: Cervical preparation prior to dilation and evacuation reduces the risk of rare complications including uterine perforation and cervical laceration. Yet, a single best approach to cervical preparation before second trimester surgical abortion does not exist. The predictability of cervical dilation is important in some settings, especially when operating room time has been scheduled and ...Read more >

Caitlin Weber, MD, Columbia University

Ultrasound is frequently performed prior to medical abortion in order to determine whether a woman is eligible to receive mifepristone and misoprostol to induce abortion, which is available up to 70 days from the last menstrual period. Many providers routinely use transvaginal sonography, or TVS, yet numerous evidence-based guidelines do not recommend the routine use ...Read more >

1 38 39 40 41 42 94